/PRNewswire/ Pediatric lupus expert Virginia Pascual, MD together with her junior colleague Simone Caielli, PhD and their team at Weill Cornell Medicine in.
/PRNewswire/ Pediatric lupus expert Virginia Pascual, MD together with her junior colleague Simone Caielli, PhD and their team at Weill Cornell Medicine in.
Share this article
Share this article
NEW YORK, June 9, 2021 /PRNewswire/ The Lupus Research Alliance (LRA) announced today that Martin Kriegel, MD PhD, of the University of Münster and Yale University is the 2021 Lupus Insight Prize Awardee for his cutting edge research in the understanding of how lupus may be triggered by the gut microbiome the community of microorganisms such as bacteria, viruses and fungi, that normally live in our guts.
The prestigious Lupus Insight Prize recognizes outstanding researchers who have made a major discovery that promises to advance the understanding of lupus with a high likelihood of improving its diagnosis or treatment. The Lupus Insight Prize was presented to Dr. Kriegel at the FOCIS (Federation of Clinical Immunology Societies) annual meeting by Gary Koretzky, MD, PhD, LRA Scientific Advisory Board Chair and Professor at Weill Cornell Medicine.
Groundbreaking New Study in Lancet Rheumatology Shows Potential Strategy for Safer Steroid Use in Lupus
Dr. Eric Morand Publishes Results Funded by LRA s Distinguished Innovator Award
News provided by
Share this article
Share this article
NEW YORK, April 1, 2021 /PRNewswire/ Results of critical work funded by the Lupus Research Alliance Distinguished Innovator Award to Dr. Eric Morand suggests a path toward making lupus treatment with steroids effective at lower doses, lessening harmful side effects.
In a study just published in
Lancet Rheumatology, Dr. Morand (with first author rheumatology fellow. Dr. Melissa Northcott) reports identifying a group of biological markers that can indicate how much steroid lupus patients have been exposed to, since the amount that is active in the body is more important than the amount taken. The paper further shows that high activity of proteins made by the immune system, called interferons, can block the effects of steroid treatmen